The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Boston Pharmaceuticals
Stock and Other Ownership Interests - Boston Pharmaceuticals; Merrimack
A phase I study of BOS172738 in patients with advanced solid tumors with RET gene alterations including non-small cell lung cancer and medullary thyroid cancer.
 
Patrick Schoffski
Consulting or Advisory Role - Adaptimmune (Inst); Blueprint Medicines (Inst); Deciphera (Inst); Eisai (Inst); Ellipses Pharma (Inst); Genmab (Inst); Intellisphere (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Plexxikon (Inst); SERVIER (Inst); Transgene (Inst)
Research Funding - Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); CoBioRes NV (Inst); Eisai (Inst); Exelixis (Inst); G1 Therapeutics (Inst); Lilly (Inst); Novartis (Inst); PharmaMar (Inst); Plexxikon (Inst)
 
Philippe Georges Aftimos
Honoraria - Roche; Synthon
Consulting or Advisory Role - Amcure; Amgen; Boehringer Ingelheim; Macrogenics; Novartis; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; MSD Oncology; Pfizer; Roche Belgium
 
Christophe Massard
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Celgene; Debiopharm Group; Genentech; Ipsen; Janssen; Lilly; MedImmune; Novartis; Orion; Pfizer; Roche; Sanofi
Research Funding - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen-Cilag; Merck; Novartis; Pfizer; Roche; Sanofi
 
Antoine Italiano
Honoraria - Bayer; Daiichi Sankyo; Epizyme; Lilly; Novartis; Roche
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Epizyme; Immune Design; Lilly; Roche
Research Funding - AstraZeneca/MedImmune; Bayer; Merck Serono; Merck Serono; MSD Oncology; PharmaMar; Roche
 
Christiane Jungels
Travel, Accommodations, Expenses - PharmaMar
 
Karen Andreas
No Relationships to Disclose
 
Mitchell Keegan
Employment - Boston Pharmaceuticals
Stock and Other Ownership Interests - Boston Pharmaceuticals
Travel, Accommodations, Expenses - Boston Pharmaceuticals
 
Peter T.C. Ho
Employment - Boston Pharmaceuticals; Epizyme
Leadership - Boston Pharmaceuticals; Epizyme
Stock and Other Ownership Interests - Boston Pharmaceuticals; Epizyme
Consulting or Advisory Role - Accent Therapeutics
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline - patent holder